explore -WSS

explore

author：entertainment 2025-09-30 00:48:00 - browse：1965

Susan Tousi is leaving Illumina to become CEO of cancer liquid-biopsy startup Delfi. Nasdaq

Delfi Diagnostics, a startup devising new ways to use routine blood draws to detect early signs of cancer, told STAT Thursday that it has appointed Susan Tousi, chief commercial officer for genomics giant Illumina, as its new CEO. She is the fourth senior executive to leave Illumina since June.

Tousi will start next week, just in time for the J.P. Morgan Healthcare Conference, while founding CEO Victor Velculescu will remain on the company’s board to help guide its research programs. Tousi’s selection is part of a bid by Delfi to expand its commercial efforts and build on the initial launch of its lung cancer screening test last fall, the latest example of growing interest in the vast and increasingly competitive liquid biopsy market.

Illumina’s own ambitions to enter this space recently came undone after a prolonged battle with U.S. and European regulators finally pushed the company to announce last month that it would divest Grail, which it had acquired for $8 billion two years earlier. Bas Verhoef, Illumina’s head of region for Europe, will serve as interim chief commercial officer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： 2023 STAT Wunderkinds: get to know the winners

Wikipedia

WSS

Health AI adoption puts security, privacy startups on investors' radar

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Readout Newsletter: Bluebird, CVS, Contineum

Why health workers in Gaza are injured or die at high rates

UnitedHealth’s board chair also owns a personal investment firm

Senate committee scrutinizes Medicare Advantage brokers

focus

explore

entertainment

Medicare details structure of new drug price negotiation program

UnitedHealth’s board chair also owns a personal investment firm

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Impact of Dobbs ruling felt at reproductive medicine meeting

How one medical school became remarkably diverse

Leading voice in opioid treatment defends methadone clinic system

New air purifier tech could be key to improving indoor air quality

Future doctors should be trained to promote social change

The cancer drug shortage isn’t new — and neither are the solutions

FDA struggles to regulate food additives, sometimes for decades

entertainment

Lawmakers consider Medicare pay reforms for doctors

Researchers explore possible ties between long Covid, menopause

Researchers explore possible ties between long Covid, menopause

HHS leader on health, climate change and biopharma emissions

Neuroscience’s long legacy of racism

SCOTUS questions limit to govt efforts to fight misinformation

hotspot

leisure time

Wikipedia

entertainment